Kane Biotech Forms Distribution Agreement with Razan Medical Trading
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) is thrilled to announce a major partnership with Razan Medical Trading for the distribution of its cutting-edge revyve™ Antimicrobial Wound Gel in the Middle East. This agreement is a significant step towards improving wound care solutions in the UAE, with the goal of providing high-quality products for both medical professionals and patients.
Highlights of the Partnership
The three-year collaboration, recently unveiled, underscores a mutual commitment to enhancing medical care. Hussain Malkawi, Managing Director of Razan Medical Trading, expressed their dedication to healthcare innovation. He noted that this partnership is a testament to their ongoing mission to transform wound care from prevention to effective healing practices.
The Importance of revyve™ in the UAE Market
Revyve™ is a state-of-the-art antimicrobial wound gel aimed at improving healing and preventing infections. This product reflects Kane Biotech's dedication to creating effective solutions in the healthcare industry. The distribution agreement with Razan Medical signifies Kane's entry into the UAE wound care market, further solidifying the brand’s aspirations for global expansion.
Previous Distribution Agreements
This partnership is not the first for Kane Biotech; it marks the third distribution agreement for revyve™. The company previously established collaborations with ProgenaCare Global LLC for the United States market and Salud Pharma S.A. for Colombia, Costa Rica, and Panama. These agreements highlight Kane's success in forming strategic partnerships to enhance product distribution.
Company Overview: Kane Biotech
Kane Biotech is at the forefront of biotechnology, concentrating on the research, development, and commercialization of technologies and products that combat microbial biofilms. Their impressive portfolio includes innovative products supported by a robust intellectual property framework, featuring 68 patents (both granted and pending), trade secrets, and trademarks. Among their notable trademarks are DispersinB®, Aledex™, coactiv+™, DermaKB™, and the newly launched revyve™.
Kane’s Ongoing Achievements
Recently, Kane Biotech achieved ISO 13485:2016 Medical Device Single Audit Program (MDSAP) certification, indicating their readiness to further commercialize revyve™ in Canada. This accomplishment underscores the company's commitment to operational excellence and adherence to regulatory standards.
About Razan Medical Trading
Established in 2015, Razan Medical Trading specializes in the distribution of medical equipment and consumables throughout the MENA region. Led by Mr. Hussain Malkawi, the company boasts over 30 years of experience in managing multinational healthcare businesses. Their local expertise strategically positions them to enhance the visibility and impact of new medical products, including revyve™.
Impact on Regional Healthcare
This collaboration aims to introduce advanced healthcare solutions in the UAE. By merging Kane Biotech’s innovative products with Razan Medical's regional market insights, the partnership is set to significantly enhance patient care and recovery processes across the region.
Conclusion
Kane Biotech's distribution agreement with Razan Medical Trading represents an exciting milestone in the company’s growth within the international wound care market. As both parties work together towards shared objectives, they are optimistic about the future of wound care solutions in the UAE, which will benefit countless patients and healthcare providers.
Frequently Asked Questions
What is revyve™ Antimicrobial Wound Gel?
Revyve™ is an innovative antimicrobial wound gel developed by Kane Biotech to enhance healing and prevent infections in wounds.
Who is partnered with Kane Biotech for the distribution of revyve™?
Kane Biotech has partnered with Razan Medical Trading to distribute revyve™ in the UAE market.
What are the benefits of using revyve™?
Revyve™ promotes effective healing through its antimicrobial properties, which help reduce the risk of infections in wounds.
When did Kane Biotech announce the distribution agreement?
The distribution agreement with Razan Medical Trading was announced on a recent date.
What other markets has Kane Biotech entered?
Kane Biotech has formed agreements for revyve™ in the United States and various countries in Central America including Colombia, Costa Rica, and Panama.